Association of interleukin-2 receptor expression with liver pathological changes in patients with chronic hepatitis B

WANG Tao; JIANG YuanYe; WANG XueWei; GAO JingJing; CAO Qin

doi:10.3969/j.issn.1001-5256.2020.11.009

Volume 36 Issue 11

Nov. 2020

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2020 > 36(11): 2441-2445

PDF( 246 KB)

Association of interleukin-2 receptor expression with liver pathological changes in patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2020.11.009

Department of Gastroenterology,Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Research funding:

Received Date: 2020-05-15
Published Date: 2020-11-20

Abstract

Abstract

Objective To investigate the association between serum interleukin( IL) and liver pathological changes in patients with chronic hepatitis B( CHB). Methods A total of 59 patients with CHB who were treated in Putuo District Central Hospital of Shanghai from February 2018 to February 2019 were enrolled as subjects,and liver biopsy was performed for all patients. According to the degree of liver inflammation,the patients were divided into mild inflammation( G1-G2) group and severe inflammation( G3-G4) group,and according to the degree of liver fibrosis,the patients were divided into mild fibrosis( S0-S2) group and severe fibrosis( S3-S4) group. Serum liver function parameters,blood lipids,interleukin-2( IL-2),interleukin-6( IL-6),interleukin-8( IL-8),and interleukin-10( IL-10)were measured for all patients. The independent samples t-test was used for comparison of normally distributed continuous data between two groups,and the Wilcoxon non-parametric test was used for comparison of non-normally distributed continuous data between two groups;the chi-square test was used for comparison of categorical data between groups. A Spearman correlation analysis was also performed.Results The degree of liver fibrosis increased with the increase in liver inflammation( rs= 0. 538,P < 0. 001). Compared with the mild inflammation group,the severe inflammation group had significantly higher serum levels of alanine aminotransferase [95. 00( 45. 00-169. 25) U/L vs 51. 00( 29. 00-88. 00) U/L,Z =-2. 625,P = 0. 009],aspartate aminotransferase [54. 50( 34. 75-84. 50) U/L vs38. 00( 30. 00-49. 00) U/L,Z =-2. 014,P = 0. 044],and gamma-glutamyl transpeptidase [91. 00( 56. 72-192. 25) U/L vs 44. 00( 24. 00-100. 00) U/L,Z =-2. 400,P = 0. 016]. The severe fibrosis group had a significantly higher serum level of high-density lipoprotein than the mild fibrosis group [0. 97( 0. 32-1. 08) mmol/L vs 1. 23( 0. 36-1. 38) mmol/L,Z =-1. 300,P = 0. 008]. The severe inflammation group had a significantly higher serum level of IL-2 receptor than the mild inflammation group [704. 00( 418. 00-1038. 00) U/ml vs 436. 00( 335. 00-555. 00) U/ml,Z =-3. 405,P = 0. 001],and the severe fibrosis group had a significantly higher serum level of IL-2 receptor than the mild fibrosis group [735. 00( 523. 00-890. 50) U/ml vs 447. 00( 351. 50-624. 50) U/ml,Z =-5. 358,P = 0. 001]. Conclusion The degree of liver inflammation is positively correlated with that of liver fibrosis,while the serum level of IL-2 receptor increases with the increase in the degrees of liver inflammation and fibrosis,indicating that IL-2 receptor can reflect the degrees of liver inflammation and fibrosis to some extent.
- hepatitis B,chronic,
- receptors,interleukin-2,
- pathology,clinical

FullText(HTML)

References(26)

References

[1] TERRAULT NA,BZOWEJ NH,CHANG KM,et al. AASLD guidelines for treatment of chronic hepatitis B[J]. Hepatology,2016,63(1):261-283.

[2] Polaris Observatory Collaborators. Global prevalence,treatment,and prevention of hepatitis B virus infection in 2016:A modelling study[J]. Lancet Gastroenterol Hepatol,2018,3(6):383-403.

[3] CALVENTE CJ,TAMEDA M,JOHNSON CD,et al. Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223[J]. J Clin Invest,2019,129(10):4091-4109.

[4] CHANG ML,YANG SS. Metabolic signature of hepatic fibrosis:From individual pathways to systems biology[J]. Cells,2019,8(11):1423.

[5] DENG YQ,ZHAO H,MA AL,et al. Selected cytokines serve as potential biomarkers for predicting liver inflammation and fibrosis in chronic hepatitis B patients with normal to mildly elevated aminotransferases[J]. Medicine(Baltimore),2015,94(45):e2003.

[6] KARLMARK KR,WEISKIRCHEN R,ZIMMERMANN HW,et al.Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis[J]. Hepatology,2009,50(1):261-274.

[7] MURAKAMI S. Soluble interleukin-2 receptor in cancer[J].Front Biosci,2004,9:3085-3090.

[8] SUN Y,GU J,LIU R,et al. IL-2/IL-6 ratio correlates with liver function and recovery in acute liver injury patients[J].APMIS,2019,127(6):468-474.

[9] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2015年更新版)[J]．临床肝胆病杂志，2015,31(12):1941-1960.

[10] ORITO E,FUJIWARA K,KANIE H,et al. Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients[J]. World J Gastroenterol,2012,18(39):5570-5575.

[11] CHEN YC,JENG WJ,CHU CM,et al. Decreasing levels of HBsAg predict HBs Ag seroclearance in patients with inactive chronic hepatitis B virus infection[J]. Clin Gastroenterol Hepatol,2012,10(3):297-302.

[12] HSU A,LAI CL,YUEN MF. Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection[J]. Curr Hepat Rep,2011,10(2):106-111.

[13] XIONG M,LI J,YANG S,et al. Influence of gender and reproductive factors on liver fibrosis in patients with chronic hepatitis B infection[J]. Clin Transl Gastroenterol,2019,10(10):e00085.

[14] CHIEN TL,WANG JH,KEE KM,et al. Factors predicting HBsAg seroclearance and alanine transaminase elevation in HBe Ag-negative hepatitis B virus-infected patients with persistently normal liver function[J]. PLo S One,2016,11(12):e0166543.

[15] SETO WK,LAI CL,IP PP,et al. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B[J]. PLo S One,2012,7(2):e32622.

[16] CHEN XL,HAN YD,WANG H. Relations of hepatic steatosis with liver functions,inflammations,glucolipid metabolism in chronic hepatitis B patients[J]. Eur Rev Med Pharmacol Sci,2018,22(17):5640-5646.

[17] DUM,ZHANG S,XIAO L,et al. The relationship between serum bilirubin and elevated fibrotic indices among HBV carriers:A cross-sectional study of a Chinese population[J]. Int J Mol Sci,2016,17(12):e2057.

[18] MILLONIG G,REIMANN FM,FRIEDRICH S,et al. Extrahepatic cholestasis increases liver stiffness(FibroScan)irrespective of fibrosis[J]. Hepatology,2008,48(5):1718-1723.

[19] RAMACHANDRAN J,SAJITH KG,PRIYA S,et al. Serum cholinesterase is an excellent biomarker of liver cirrhosis[J]. Trop Gastroenterol,2014,35(1):15-20.

[20] JIANG Q,MAO R,WU J,et al. Platelet activation during chronic hepatitis B infection exacerbates liver inflammation and promotes fibrosis[J]. J Med Virol,2019.[Online ahead of print]

[21] SEIDLER S,ZIMMERMANN HW,WEISKIRCHEN R,et al. Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes[J]. BMC Gastroenterol,2012,12:38.

[22] LAN T,CHANG L,WU L,et al. IL-6 plays a crucial role in HBV infection[J]. J Clin Transl Hepatol,2015,3(4):271-276.

[23] WANG X,YAN Z,YE Q. Interleukin-6 gene polymorphisms and susceptibility to liver diseases:A meta-analysis[J].Medicine(Baltimore),2019,98(50):e18408.

[24] YANG K,GUAN SH,ZHANG H,et al. Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy[J]. Int J Mol Sci,2014,15(11):21286-21298.

[25] SUH YG,KIM JK,BYUN JS,et al. CD11b(+)Gr1(+)bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice[J]. Hepatology,2012,56(5):1902-1912.

[26] LIU Y,CHENG LS,WU SD,et al. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection[J]. Clin Sci(Lond),2016,130(11):907-919.

Relative Articles

[1]	Chen Xi, Zhao WenJing, Sun Yan, Yin HaiYan. Value of baseline HBsAg quantification in predicting the clinical effect of pegylated interferon α-2b in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2020, 36(8): 1723-1726. doi: 10.3969/j.issn.1001-5256.2020.08.009
[2]	Yu SiMiao, Cui YanFei, Tian Miao, Su PengYu, Zhang Ning, Zhu Yun, Wang LiFu, Sun YongQiang, Jing Jing, Sang XiuXiu, Xu WenTao, Wang LiPing, Wang RuiLin. Clinical and pathological features of hepatomegaly of unknown origin: An analysis of 87 cases[J]. Journal of Clinical Hepatology, 2020, 36(1): 132-135. doi: 10.3969/j.issn.1001-5256.2020.01.029
[3]	Sun Qi, Jin XinYao, Wang CaiYing, Yang YanLi. Clinicopathological features of perivascular epithelioid cell tumor of the liver: An analysis of 4 cases[J]. Journal of Clinical Hepatology, 2020, 36(3): 646-648. doi: 10.3969/j.issn.1001-5256.2020.03.035
[4]	Miao Qi, Chen XiaoYu. Liver histopathological diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 728-730. doi: 10.3969/j.issn.1001-5256.2020.04.003
[5]	Ji LinXiu, Yang XingXiang. Liver histological changes and clinical features in chronic hepatitis B with normal or mildly elevated alanine aminotransferase[J]. Journal of Clinical Hepatology, 2020, 36(4): 778-782. doi: 10.3969/j.issn.1001-5256.2020.04.014
[6]	Ye LiHong, Wang ChongKui, Jin Peng, Zhao LiangLiang, Zhang HaiCong, Liu ZhiQuan, Tang YaFang. Clinicopathological features of drug-induced liver injury or primary biliary cholangitis with vanishing bile duct syndrome[J]. Journal of Clinical Hepatology, 2019, 35(2): 359-363. doi: 10.3969/j.issn.1001-5256.2019.02.023
[7]	Yang RuiYuan, Zhao XinYan. Significance of liver histopathological examination in diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2018, 34(6): 1172-1175. doi: 10.3969/j.issn.1001-5256.2018.06.007
[8]	Chen YiHua, Wang Chao, Jiang Rui, Tang ShanHong, Luo Yan, Ceng DongMei, He XiaoYan, Shi GuangJing. Pathological features of hepatic epithelioid hemangioendothelioma: An analysis of 5 cases[J]. Journal of Clinical Hepatology, 2018, 34(11): 2356-2359. doi: 10.3969/j.issn.1001-5256.2018.11.017
[9]	Wang TingTing, Lu ChangLi, Fan XiaoLi, Yang Li. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2179-2185. doi: 10.3969/j.issn.1001-5256.2017.11.026
[10]	Li Wei, Xu KuiHua, Zhao ShouSong. Association between liver pathology and clinical features in patients with chronic HBV infection and slightly elevated alanine aminotransferase[J]. Journal of Clinical Hepatology, 2017, 33(11): 2123-2126. doi: 10.3969/j.issn.1001-5256.2017.11.014
[11]	Wang GuoHua, Cong LeLe, Zhao Zhao, Wang YueChao, Dai Jing, Zhao Ping. Clinical and pathological features of cryptogenic liver cancer[J]. Journal of Clinical Hepatology, 2016, 32(4): 732-734. doi: 10.3969/j.issn.1001-5256.2016.04.025
[12]	Chen Li, Zhou XingBei, Wen DanFeng, Wu XueJun, Yang LiJun, Sun Li, Tan YouWen. Clinical features and liver pathology in chronic hepatitis B virus-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2015, 31(9): 1430-1433. doi: 10.3969/j.issn.1001-5256.2015.09.016
[13]	Gao JiaLin, Yang ZongGuo, Chen XiaoRong, Xu QingNian, Lu YunFei. Analysis of association between HSP70 expression in tumor tissues and clinicopathological characteristics of HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(5): 733-736. doi: 10.3969/j.issn.1001-5256.2015.05.024
[14]	Miao Qi, Ma Xiong. Significance of clinical pathology in diagnosis and treatment of autoimmune liver diseases[J]. Journal of Clinical Hepatology, 2014, 30(5): 385-389. doi: 10.3969/j.issn.1001-5256.2014.05.001
[15]	Li GuiMei, Yang ZhiHui, Gao Hong, Yin ZhengJin. Clinicopathological features of hepatocellular lymphoepithelioma- like carcinoma: case report and review of the literature[J]. Journal of Clinical Hepatology, 2013, 29(11): 871-873. doi: 10.3969/j.issn.1001-5256.2013.11.017
[16]	Chang BinXia, Teng GuangJu, Sun Ying, Zhao Jun, Zhang Wei, Huo DanDan, Zheng RuiDan, Zou ZhengSheng, Li BaoSen. Relationship between laboratory parameters and liver pathology in patients with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2013, 29(11): 839-843. doi: 10.3969/j.issn.1001-5256.2013.11.010
[17]	Zhu Zhen, Cong WenMing. Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011[J]. Journal of Clinical Hepatology, 2013, 29(1): 42-44.
[18]	Liu HaiPing, Cong WenMing. Hepatocellular adenoma: new understandings of molecular pathology and novel model of clinical diagnosis and therapy[J]. Journal of Clinical Hepatology, 2013, 29(11): 801-804. doi: 10.3969/j.issn.1001-5256.2013.11.001
[19]	Wang TaiLing, Zhao XinYan. Pathological features of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 577-580.
[20]	Zhang LiaoYun, Li DeHua, Zhang LingRong, Wang ShouYi. The study of the level of serum soluble interleukin 2 receptor in patients with viral hepatitis E.[J]. Journal of Clinical Hepatology, 2001, 17(2): 87-88.

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	李述美，刘冰，彭思璐，刘仁伟，李铃，孙宏. 慢性乙型肝炎患者HBV DNA载量及血清IL-2R、GP73、miR-21与HBVM表达模式、肝组织病理学改变的相关性. 临床和实验医学杂志. 2024(10): 1017-1021 .
2.	李述美，刘冰，刘仁伟，杨洁. GP73、IL-2R、miR-21预测慢性乙肝患者显著肝纤维化的临床价值. 重庆医学. 2024(23): 3575-3580 .
3.	王娟霞，陈馨悦，魏世博，孙新策，朱浩宇，连唐悠悠，杜雨峰. 慢性乙型肝炎患者肝脏炎症程度预测模型的研究. 中国实用内科杂志. 2023(05): 390-395 .
4.	刘俊玲，刘芮菡. 慢性乙型肝炎患者血清IL-2R、CK18、GP73与肝组织病理学改变和肝功能指标的相关性. 中国卫生工程学. 2022(03): 469-471+474 .
5.	王楠. 血清OPN、IL-2水平与慢性乙型肝炎患者肝纤维化程度的相关性. 中国民康医学. 2022(20): 127-129 .
6.	许余丽，王芳，洪梅，吴海珍. 目的性责任细分化护理对乙型肝炎患者主观幸福感及疾病知识掌握的影响. 长春中医药大学学报. 2021(04): 858-860 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (4639) PDF downloads(97)

Association of interleukin-2 receptor expression with liver pathological changes in patients with chronic hepatitis B

DOI: 10.3969/j.issn.1001-5256.2020.11.009